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Epidermolytic hyperkeratosis is a dominantly in-
herited ichthyosis, frequently associated with muta-
tions in keratin 1 or 10 that result in disruption of
the keratin ®lament cytoskeleton leading to keratino-
cyte fragility. In addition to blistering and a severe
disorder of corni®cation, patients typically display an
abnormality in permeability barrier function. The
nature and pathogenesis of the barrier abnormality
in epidermolytic hyperkeratosis are unknown, how-
ever. We assessed here, ®rst, baseline transepidermal
water loss and barrier recovery kinetics in patients
with epidermolytic hyperkeratosis. Whereas baseline
transepidermal water loss rates were elevated by
approximately 3-fold, recovery rates were faster in
epidermolytic hyperkeratosis than in age-matched
controls. Electron microscopy showed no defect in
either the corni®ed envelope or the adjacent corni-
®ed-bound lipid envelope, i.e., a corneocyte scaffold
abnormality does not explain the barrier abnormal-
ity. Using the water-soluble tracer, colloidal lantha-
num, there was no evidence of tracer accumulation
in corneocytes, despite the fragility of nucleated
keratinocytes. Instead, tracer, which was excluded in
normal skin, moved through the extracellular
stratum corneum domains. Increasing intercellular
permeability correlated with decreased quantities and
defective organization of extracellular lamellar
bilayers. The decreased lamellar material, in turn,
could be attributed to incompletely secreted lamellar
bodies within granular cells, demonstrable not only
by several morphologic ®ndings, but also by
decreased delivery of a lamellar body content
marker, acid lipase, to the stratum corneum inter-
stices. Yet, after acute barrier disruption a rapid
release of preformed lamellar body contents was
observed together with increased organelle contents
in the extracellular spaces, accounting for the accel-
erated recovery kinetics in epidermolytic hyperkera-
tosis. Accelerated recovery, in turn, correlated with a
restoration in calcium in outer stratum granulosum
cells in epidermolytic hyperkeratosis after barrier
disruption. Thus, the baseline permeability barrier
abnormality in epidermolytic hyperkeratosis can be
attributed to abnormal lamellar body secretion,
rather than to corneocyte fragility or an abnormal
corni®ed envelope/corni®ed-bound lipid envelope
scaffold, a defect that can be overcome by external
applications of stimuli for barrier repair. Key words:
corni®ed envelope/intermediate ®laments/keratin/stratum
corneum/transepidermal water loss. J Invest Dermatol
117:837±847, 2001
T
he epidermis is a homeostatic, self-renewing tissue that
expresses differentiation-speci®c genes sequentially as
keratinocytes move outward from the basal to the
granular cell layer (SG). Keratins are among the most
abundant proteins produced during this vectorial
process of epidermal differentiation. Whereas expression of keratins
5 and 14 is restricted to the basal cell compartment, keratins 1 and
10 are produced in all suprabasal nucleated cell layers (Roop, 1995).
In the nucleated cell layers, these keratins are organized into
®lament bundles that loop between desmosome plaques and the
nuclear envelope providing a cytoskeleton that protects keratino-
cytes from mechanical injury (Fuchs and Cleveland, 1998). As the
keratinocytes terminally differentiate, keratins 1 and 10 as well as
several other corni®ed envelope (CE) proteins form a rigid,
chemically and mechanically resistant structure that replaces the
plasma membrane (Nemes and Steinert, 1999; Steinert and
Marekov, 1999; Steinert, 2000). The CE, in turn, forms a scaffold
upon which the lipid-enriched extracellular matrix is organized
into lamellar bilayer structures that mediate the permeability barrier
function of the outermost layer of the epidermis, the stratum
corneum (SC) (Jackson et al, 1993; Elias et al, 1998).
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The dual-compartment, corneocyte±extracellular lamellar lipid-
enriched matrix of the SC serves as a protective barrier not only
against external insults, but also against excess transepidermal water
loss (TEWL) (Grubauer et al, 1989). Any perturbation of the
permeability barrier initiates a rapid and ef®cient repair response in
the underlying epidermis. Regardless of the speci®c nature of the
barrier insult, i.e., mechanical (e.g., tape stripping) or chemical
(e.g., solvent or detergent treatment), a metabolic response ensues
in the underlying epidermis that leads to restoration of normal
function (Elias, 1996). The initial response comprises an immediate
exocytosis of the preformed pool of lamellar bodies from the
outermost SG cell layer (Menon et al, 1992a; Elias et al, 1998).
Cholesterol, fatty acid, and ceramide synthesis then increase over
the next 6±9 h (Harris et al, 1997), leading to accelerated formation
and further secretion of nascent lamellar bodies (Menon et al,
1992a). This response enables the re-accumulation of lipids in the
SC extracellular spaces, reformation of membrane bilayers, and
restoration of baseline barrier function (Grubauer et al, 1987).
Whereas the importance of the lipid matrix for the maintenance
of cutaneous barrier function is undisputed, the contribution of the
corneocyte to the permeability barrier is less clear. A potential role
for the CE scaffold in the organization of the extracellular lamellar
bilayer system is suggested by lamellar ichthyosis, where transglu-
taminase I mutations (Huber et al, 1995; Russell et al, 1995) result
not only in a defective CE formation but also abnormal permea-
bility barrier function (Lavrijsen et al, 1993; Elias et al, 2001). The
enhanced TEWL in lamellar ichthyosis has been attributed to
truncation and fragmentation of extracellular lamellar arrays, which
correlate with the CE defect (Elias et al, 2001), supporting a scaffold
role for the CE in bilayer formation.
Mutations in keratin 1 and keratin 10 have been identi®ed as the
cause of the autosomal dominant form of ichthyosis, epidermolytic
hyperkeratosis (EHK, also termed bullous congenital ichthyosiform
erythroderma (BCIE), OMIM113800) (Cheng et al, 1992; Chipev
et al, 1992; Rothnagel et al, 1992). The keratin 1/10 mutations
function in a dominant-negative manner to disrupt the keratin
®lament network within the keratinocyte cytosol. Filaments retract
from their attachments to desmosomal plaques and form clumps of
perinuclear shells (Anton-Lamprecht, 1983). Skin fragility to
mechanical trauma, which is most pronounced in the neonatal
period, is an expected consequence of this cytoskeletal defect,
analogous to the fragile skin phenotype of epidermolysis bullosa,
where mutations in keratins 5 or 14 produce cytoskeletal defects in
the epidermal basal layer (Bonifas et al, 1991; Coulombe et al, 1991;
Lane et al, 1992). The hyperkeratosis and accompanying defect in
permeability barrier function are additional clinical features of EHK
(Frost et al, 1968), the pathogenesis of which is less clear.
Speci®cally, whether the barrier defect is due to a fragile
keratinocyte, i.e., a defective corneocyte/CE scaffold, or other
abnormalities is not known. To dissect the pathogenesis of the
barrier abnormality in EHK, we assessed three alternative mech-
anisms: (i) a fragile corneocyte leading to increased transcellular
permeability; (ii) an ineffective CE scaffold; (iii) aberrant lamellar
body (LB) secretion. Lanthanum tracer studies revealed an
intercellular rather than a transcellular route of increased water
loss in EHK, ruling out a fragile corneocyte as the basis for the
abnormality. Increased intercellular water movement correlated, in
turn, with a decrease in the quantities and abnormal organization of
the extracellular lamellar bilayer system. Finally, the decreased
lamellar bilayers were associated with an accumulation of
unsecreted LB in the outer SG under baseline conditions. With
acute barrier disruption, however, a loss of the epidermal calcium
gradient occurred that initiated a rapid release of preformed LB and
appearance of organelle contents in the extracellular domains,
resulting in accelerated rates of barrier recovery.
MATERIALS AND METHODS
Patients We investigated four patients (one female, three male, aged
12±45 y) with clinically typical EHK (Table I). The diagnosis was
con®rmed by the presence of prominent hyperkeratosis, coarse
keratohyalin granules, and vacuolization of the upper stratum spinosum
and SG on histopathology. In some sections we additionally found
acantholysis of the stratum spinosum and SG. This skin phenotype had
been present in all patients since birth. Further work-up did not
demonstrate any clinical or laboratory abnormalities. Mutation analysis
revealed novel mutations in keratin 1 or 10 in two patients (Table I; in
Table I. Characteristics of EHK patients
Patient # Gender Age Clinical phenotype Mutation Biopsy sites Scale
1 M 29 Generalized, ¯exural accentuation K10a (coil domain) Lower arm +
2 F 12 Generalized, annular ±ab Abdomen +
3 M 44 Generalized, ¯exural accentuation ±abc Lower arm +
4 M 17 Generalized, annular K1d (tail domain) Lower leg ±
aDepartment of Biochemistry, University of Salzburg.
bHot spot analysis of K1/10; no mutations were detected.
cReduced epidermal immunolabeling of K10, Department of Dermatology, General Hospital Salzburg.
dJefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia.
Table II. Material available for pathogenesis studies
Patient #
Material at
baseline
Material after
acute disruption
Assessment of
LB secretiona
Acid lipase
secretiona
Calcium
localizationa
Lanthanum
perfusiona
OsO4 post-
®xation
RuO4 post-
®xation
Pyridine
treatmentb
1 Biopsy
Scale
6 h
72 h
+
±
+
±
+
±
+
±
+
±
+
+
±
+
2 Biopsy
Scale
6 h
±
+
±
+
±
±
±
+
±
+
±
+
+
±
+
3 Biopsy
Scale
3 h
±
+
±
+
±
+
±
+
±
+
±
+
+
±
±
4 Biopsy
Scale
±
±
+
±
+
±
±
±
+
±
+
±
+
+
±
±
aAnalysis possible in biopsies, but not in scale samples.
bBaseline only.
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patient 1 a mutation was detected in the coil domain 1 A of keratin 10
whereas in patient 4 the mutation was located in the tail of keratin 1).
An additional patient displayed reduced immunostaining for keratin 10,
but neither keratin 1 or keratin 10 mutations were detectable in this or
the other remaining patient on hot spot analyis. Others have noted that a
substantial proportion of patients with the EHK phenotype lack keratin 1
or 10 mutations (Porter et al, 1996; Fuchs and Cleveland, 1998). Skin
from EHK patients and control subjects (three healthy male volunteers,
aged 31±32 y) comprised our group of controls (Table III). None of the
EHK or control subjects had employed any external medications or
emollients to the studied skin areas for at least 2 wk prior to assessment
of barrier function. Additional controls included historical material from
normal human skin, and biopsies from a variety of individuals with other
disorders of corni®cation (Table III).
Functional studies To assess epidermal permeability function we
measured TEWL on a 1.13 cm2 area of the volar aspect of the forearm
in three EHK subjects using an evaporimeter (ServoMed, Stockholm,
Sweden). TEWL values were registered in g per m2 per h after
equilibration of the probe on the skin (> 60 s). All recordings were
made by the same investigator (M.S.). Volunteers underwent a 15 min
premeasurement rest period. Environment-related variables at the time of
the study were: ambient air temperature 21.9°C±26.6°C; skin surface
temperature 30.4°C±34.4°C, ambient air humidity 23%±49%;
atmospheric H2O pressure 4.4±14.8 mmHg. Excess air convection was
prevented by shielding the measurement zone. TEWL was measured
both under baseline conditions and following acute barrier disruption by
either repeated cellophane tape stripping or acetone swabbing of the
lower forearm. Barrier recovery kinetics then were assessed by measuring
TEWL at 3, 6±7, 16, 24, 48, 96, 120, and 144 h after acute disruption.
For calculation of the percentage change in TEWL, the following
formula was used: 1 ± [(TEWL immediately after stripping ± TEWL at
indicated time)/(TEWL immediately after stripping ± baseline
TEWL)] 3 100%.
Pathophysiology studies To assess the pathophysiologic basis for the
barrier abnormality in EHK, we utilized the sequence shown in Fig 1,
recently applied to Harlequin ichthyosis (Elias et al, 2000b) and lamellar
ichthyosis (Elias et al, 2001). If barrier function was abnormal in an EHK
individual, we next assessed whether the abnormality was due to leaky
corneocytes resulting in transcellular water movement (as a putative
downstream consequence of the keratinocyte fragility that is a well-
known feature of EHK), or to enhanced intercellular permeability. As
the barrier abnormality was linked, instead, to enhanced intercellular
permeability, we next assessed extracellular lamellar bilayer quantity and
organization. If abnormal, we then sought whether the structural defect
in the lamellar bilayers was due to an abnormal CE±corneocyte scaffold
or to ineffective LB secretion. Biopsies from EHK skin were taken
immediately before and 3 and 6 h after acute barrier disruption.
Assessment of permeability pathway by lanthanum perfusion The perfusion
pathway was assessed in all subjects by immersion of biopsies and/or
scale in 4% lanthanum nitrate in 0.05 M Tris buffer containing 2%
Table III. Assessment of lamellar body secretion in EHK versus controls
Type of samples
(case #) Lamellar bilayers
Contents of SG±SC
interface Entombed LB
Interstices-width/
corneocyte ratio Lipase localization in SC
EHK
1 Decreased Decreased Present Increased Decreased Intercellular
2 Decreased Decreased Present Increased Decreased Intercellular
3 Decreased Decreased Present Increased Decreased Intercellular
4 Decreased Decreased Present Increased Decreased Intercellular
Normal
controls (n = 3)
Replete Replete None Normal All Intercellular
Other ichthyoses
CIE (n = 4)a Decreased Decreased Present Increased Decreased
LI (n = 4)b Replete (dimensions Replete
abnormal)
None Normal All Intercellular
NLSDI (n = 2)c Clefts Decreased Some present Normal Mostly Intercellular
aCongenital ichthyosiform erythroderma (Menon et al, 1992b).
bLamellar ichthyosis (Elias et al, 2001).
cNeutral lipid storage disease (Williams et al, 1985).
Figure 1. Pathogenesis ¯ow chart for the
analysis of the barrier abnormality in
disorders of keratinization. First, functional
assessments are used to determine TEWL levels in
ichthyotic skin. If TEWL abnormalities are
present, lanthanum perfusion is employed to
distinguish transcellular from intercellular
permeability pathways. In the case of an inter-
cellular abnormality, a battery of ultrastructural
methods is then applied to detail the morphologic
basis for the intercellular defect. aElias et al, 1981;
bElias et al, 2001; cElias et al, 2000b; dpresent
study.
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glutaraldehyde, 1% paraformaldehyde, pH 7.4, for 1 h at room
temperature (Table II) (Elias et al, 1981). After lanthanum perfusion, the
samples were washed and processed for electron microscopy, as described
below.
Assessment of lamellar bilayer system and CE-associated structures Using a
combination of osmium tetroxide (OsO4) and ruthenium tetroxide
(RuO4) post®xation with pyridine pretreatment, it is possible to assess
the integrity of the intercellular lamellar bilayer system in relation to the
CE/corneocyte-bound lipid envelope (CLE) scaffold (Elias, 1996; Elias
et al, 2000b). Again, scale and biopsy samples were available for these
studies (Table II). Brie¯y, all samples were pre®xed in half-strength
Karnovsky's ®xative, followed by post®xation in 1% OsO4 and 0.2%
RuO4, as described previously (Hou et al, 1991). Some samples were
then treated for 2 h with absolute pyridine to further enhance the
visualization of the CE/CLE membrane complex, as described recently
(Elias et al, 2000b; 2001). After post®xation, all samples were dehydrated
in a graded ethanol/propylene oxide series, and embedded in an Epon-
epoxy mixture. Ultrathin sections were collected and assessed either
unstained or after further lead citrate contrasting in a Zeiss 10 A electron
microscope operated at 60 kV.
Assessment of LB secretion Several morphologic criteria have been used
to assess the integrity of the LB secretory process, including (i) the
amount of secreted material at the SG±SC interface (Menon et al,
1992a); (ii) the extent that the SC interstices are replete with lamellar
bilayers (Menon et al, 1992b); and (iii) the presence of ``entombed'' LB
within the corneocyte cytosol (Elias et al, 1998). We assessed all of these
criteria (Table III) and, in addition, utilized the delivery of a lipid
hydrolase (acid lipase), which is concentrated in LB (Menon et al, 1986),
as cytochemical indicator of the extent of secretion (Menon et al,
1992b). Aldehyde-pre®xed samples were microwave-incubated with
substrate containing 0.2% Tween 85 (6 inhibitor tetrahydrolipstatin,
200 mM) in a lead-capture, cytochemical method that depicts the
localization of acid lipase, as described previously (Rassner et al, 1997).
Prior studies on nomal controls showed abundant enzyme activity in the
SC interstices, with little activity in the corneocyte cytosol (Menon et al,
1992b; Elias et al, 2001) (see Fig 8(D) also). Conversely, in some
disorders of corni®cation, acid lipase is not delivered normally, and
enzyme activity is retained in the corneocyte cytosol (Ghadially et al,
1992; Menon et al, 1992b) (Table III). The samples for ultrastructural
cytochemistry were post®xed in OsO4 and processed as above.
Ion capture cytochemistry For ultrastructural calcium localization, frozen
biopsy samples (before and after acute barrier disruption, see above) were
®xed in 2% paraformaldehyde, 2% glutaraldehyde, 0.09 M potassium
oxalate, containing 0.04 M sucrose. Samples were subsequently ®xed
overnight at 4°C, and then post®xed in 1% OsO4 containing 2%
potassium pyroantimonate, pH 7.4, for 2 h at 4°C in the dark. Tissue
samples then were washed in alkalinized water (pH 10) and transferred
to ethanol solutions for dehydration and embedding, as above.
Statistical analyses Statistical analyses were performed using a paired
or unpaired Student's t test, as appropriate. Data are expressed as mean 6
SEM.
RESULTS
EHK patients display abnormal baseline barrier function,
but accelerated barrier recovery kinetics We ®rst assessed
barrier function in the three EHK patients who where available for
functional studies. As previously shown for EHK (Frost et al, 1968),
baseline TEWL rates were markedly increased, with a mean of
19.7 6 1.9 g per m2 per h in patients versus 7.43 6 1.2 g per m2
per h in the three normal controls (p < 0.006, not shown). Yet, the
kinetics of barrier recovery after comparable, initial insults (i.e., tape
stripping to a maximal TEWL of 100 g per m2 per h) showed an
accelerated repair response for the EHK patients versus the three
control subjects (Fig 2). In addition, we incidently noted a
remarkably fast healing of the skin biopsy sites in EHK patients.
The early, more rapid recovery phase was followed by a later
normalization of barrier recovery rates by 96 h (not shown). By 1
wk, TEWL levels had returned to approximately 80% of
pretreatment values in both EHK and controls. Thereafter,
controls and EHK patients returned to baseline levels in parallel.
These results show that EHK patients, despite a prominent baseline
barrier abnormality, exhibit accelerated barrier recovery rates after
acute insults.
The enhanced water movement in EHK occurs via
intercellular domains We next assessed whether the baseline
barrier abnormality in EHK could be assigned to enhanced
intercellular or transcellular movement of water, utilizing divalent
colloidal lanthanum as a tracer to localize the sites of enhanced
water movement. Prior studies have shown that lanthanum is
Figure 2. Barrier recovery after tape stripping is accelerated in
EHK epidermis. The volar forearm of EHK and normal subjects was
tape-stripped, and TEWL was measured with time following barrier
disruption (time 0). Accelerated barrier recovery, although evident at all
early time points after disruption (i.e., 0±48 h), was signi®cant only at
48 h, because of the small number of patients (*p < 0.05 vs normal
control values). At later time points, barrier recovery of EHK individuals
paralleled the recovery of normal skin, and at 2±5 d, barrier recovery
slowed, resulting in the higher-than-normal baseline TEWL levels
characteristic of EHK.
Figure 3. Increased water movement occurs
via intercellular pathways. Freshly obtained
biopsies from EHK were exposed for 1 h to 4%
colloidal lanthanum nitrate tracer in 0.05 M Tris
buffer, pH 7.4, containing 2% glutaraldehyde and
2% paraformaldehyde, followed by post®xation in
OsO4. (A), (B) Tracer is observed throughout the
SC interstices (arrows), but was excluded from the
corneocyte cytosol. OsO4 post®xation. Scale bars:
0.5 mm.
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excluded from normal SC (Elias et al, 1977), and we con®rmed this
®nding here in the normal control samples (not shown). In
contrast, lanthanum penetrated throughout the SC in EHK
(Fig 3A). Moreover, in all cases and at all levels of the SC, the
tracer was limited to the SC interstices (Fig 3A, B); i.e., little or no
tracer was found within the cytosol of individual corneocytes.
These results show that, despite evidence of keratinocyte fragility
within the nucleated layers, the permeability barrier abnormality in
EHK can be ascribed to enhanced movement of water, exclusively
via SC extracellular domains.
Although extracellular lamellar membranes are reduced and
abnormal in EHK, the CE/CLE scaffold is normal We next
explored the basis for increased extracellular water movement in
EHK, assessing ®rst the lamellar bilayer system. The lamellar bilayer
system was markedly abnormal in all EHK samples, as assessed in
RuO4 post®xed samples (Fig 4A±C). With the exception of a few
foci (Fig 4A, B, insert, arrows), the amount of bilayer material
generally was reduced (Fig 4C, D). Wherever bilayers were
present, they appeared disrupted/interrupted by numerous clefts
and lacunae that were ®lled with amorphous material (Fig 4A±C,
asterisks). Both the reduction in numbers of lamellae and the
interruptions of the bilayers by clefts could account for enhanced
water movement through the SC interstices. Yet, the precise
intercellular pathway of increased water movement could not be
ascertained because lanthanum cannot be identi®ed with certainty
Figure 4. Extracellular lamellar bilayer
structures are abnormal in EHK. (A±C) Clefts
and lacunae are present througout the SC
interstices (asterisks). (C) Overall, the amount of
bilayer material is reduced. (A, B, D,) Stretches of
intact, normal-appearing bilayers are only focally
present (arrows). RuO4 post®xation. Scale bars:
0.5 mm.
Figure 5. CE and CLE appear normal in
EHK. (A) CE (arrows) in EHK appear largely
normal, although there is some variation in
thickness. (B) CLE (arrowheads) also appear
completely normal in EHK. (A) OsO4
post®xation; (B) OsO4 post®xation after pyridine
pretreatment (see Methods). Scale bars: 0.25 mm.
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in RuO4 post®xed samples. We next assessed whether the
abnormalities in lamellar membrane structure are associated with
abnormalities in the CE/CLE scaffold, as occurs in lamellar
ichthyosis (Elias et al, 2001). Yet, despite the known association of
keratins 1/10 with the CE (Steinert and Marekov, 1995), we noted
no major abnormalities in CE structure or dimensions (Fig 5A),
Figure 6. Arrays of LB beneath plasma
membrane indicate a secretory defect in
EHK. Although the overall number of LB is
normal in EHK, arrays of individual organelles
remain restricted beneath the apical plasma
membrane of outermost granular (SG) cells (A, B,
arrows). (C) Lack of LB secretion results in a
paucity of extracellular deposits at the SG±SC
interface (asterisks). RuO4 post®xation. Scale bars:
0.5 mm.
Figure 7. LB content is entombed within
corneocyte cytosol. (A, B) Entombed LB are
found within the cytosol of corneocytes (A, B,
short open arrows; C, solid arrow). Note again the
presence of lacunae (asterisks) and areas of reduced
and abnormal bilayer structures (B, C). (C) The
encased LB contents focally form bilayer structures
within the cytosol. RuO4 post®xation. Scale bars:
0.25 mm.
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and an intact CLE on the outer surface of corneocytes in all EHK
samples (Fig 5B). We did not quantitate the extent of CLE
biochemically, because prior studies have demonstrated normal
quantities of covalently bound ceramide in EHK scale (Paige et al,
1994). These results show ®rst that an abnormality in the SC
extracellular lamellar bilayer system is present in the SC of EHK
under baseline conditions, which accounts for the barrier
abnormality in EHK. They also show that the membrane
abnormality cannot be ascribed to morphologically detectable
abnormalities in the CE/CLE scaffold.
LB secretion is impaired in EHK under baseline
conditions We next assessed an alternative explanation for the
depletion of extracellular lamellar bilayers in EHK, i.e., abnormal
production or secretion of LB. In all baseline EHK biopsies, we
observed normal numbers of LB in the upper spinous and granular
layers, as well as normal lamellar contents within individual
organelles. Thus, LB production appears to be unimpaired in EHK.
In contrast, LB secretion from outer SG cells did not occur
normally. A distinctive feature was the appearance of arrays of
individual organelles, localized within the peripheral cytosol, just
beneath the plasma membrane (Fig 6A, B). This feature appeared
primarily in cells of the outer SG layer, which also displayed
retracted tono®lament bundles (not shown). Further evidence of
impaired secretion in EHK included a striking paucity of secreted
lamellar contents at the SG±SC interface (Fig 6A, C), and evidence
of entombed LB in the form of organelle contents, encased within
the cytosol of corneocytes (Fig 7A±C).
Figure 8. Further evidence of impaired
secretion in EHK: acid lipase is retained
within corneocytes. (A, B) The LB hydrolase,
acid lipase, is largely retained within the cytosol of
corneocytes in EHK (arrowheads). (C) Retained
activity is colocalized with entombed LB. (D)
Normal human skin demonstrates hydrolase solely
in the SC interstices, indicative of effective
secretion. OsO4 post®xation. Scale bars: 0.5 mm.
Figure 9. Basis for accelerated barrier
recovery in EHK epidermis. (A, B) (6 h post-
tape stripping): No LB remain in cytosol of
granular cells (SG), indicated by release of lipase
activity into the intercellular spaces (B, arrows).
Extent of release of contents also is shown at level
of SC: no entombed organelles or cytosolic lipase
activity remain in corneocyte cytosol. (C) (3 d
post-tape stripping): Reappearance of additional
foci of replete lamellar bilayers at time point when
barrier recovery is accelerated (cf. Fig 2). (D) (6 h
post-tape stripping): Lanthanum perfusion
demonstrates substantial blockade of tracer
movement at SG±SC interface, although foci of
tracer (arrow) continue to penetrate the SC
interstices. (A, B, D) OsO4 post®xation; (C)
RuO4 post®xation. Scale bars: (A, B, D) 0.5 mm;
(C) 0.25 mm.
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To further ascertain whether secretion is impaired in EHK, we
next assessed the distribution of an enzyme cytochemical marker of
LB contents, i.e., acid lipase (Menon et al, 1986), in EHK versus
control samples. As previously reported (Menon et al, 1992b), LB-
derived hydrolase contents were delivered in toto to the SC
interstices in normal SC (Fig 8D), leaving no residual, detectable
activity within the corneocyte cytosol (Table III). In contrast,
whereas EHK subjects displayed comparable labeling of cytosolic
LB (Fig 8B), activity at the SG±SC interface and in the SC
interstices appeared strikingly reduced (Fig 8C), further regulated
by the presence of abundant, retained deposition product in the
cytosol of individual corneocytes (Fig 8A, C). Moreover, in some
corneocytes retained enzyme activity colocalized with residual,
entombed LB contents (Fig 8C). Together, these results show that,
whereas LB production is normal in EHK, impaired LB secretion
accounts for the diminished extracellular lamellar bilayers that lead
to the permeability barrier abnormality in EHK.
Inverse calcium signaling of LB secretion accounts for
accelerated barrier recovery in EHK Whereas baseline barrier
function is abnormal, the kinetics of barrier recovery are faster in
EHK than in normal skin (Fig 2). To assess the basis for accelerated
barrier recovery in EHK, we next examined lanthanum perfusion,
LB secretion, and SC membrane structures 3, 6, and 72 h after
acute disruption by either tape stripping or acetone treatment. At
both 3 and 6 h, more extensive cytolysis was evident throughout
the outer nucleated cell layers than in nonperturbed EHK
epidermis (not shown). Yet, in contrast to baseline EHK
epidermis, few LB remained in these disrupted cells; instead,
organelle contents appeared in the intercellular spaces throughout
the outer epidermis (Fig 9, cf. Fig 6). Further evidence for release
of organelle contents also could be seen in the SC. Few corneocytes
displayed entombed LB contents (Fig 9, cf. Fig 7), and lipase
activity was found between, rather than within, individual
corneocytes (Fig 9, cf. Fig 8). These ®ndings correlated with the
presence of more widespread foci of normal-appearing membrane
bilayers (Fig 9; however, the absolute quantities were still lower
than in normals). Finally, after acute perturbations, resulting in LB
release, lanthanum was largely (but incompletely) excluded from
the SC interstices (Fig 9D).
Finally, to assess whether the combination of baseline secretory
defect and accelerated recovery is due to modulations in the
epidermal calcium gradient, we employed ion capture cytochem-
istry. At baseline, we observed an accumulation of extracellular and
intracellular Ca2+ in the outer SG cells with low visible levels in the
SC, comparable to normal skin (Fig 10A, B). Loss of the epidermal
calcium gradient with acute barrier disruption either by tape
stripping or by acetone treatment occurred normally in EHK skin
(Fig 10C, D). Loss of the calcium gradient was accompanied by
Figure 10. Baseline Ca2+ distribution and
loss of Ca2+ gradient is similar to normals in
EHK. (A, B) A comparable Ca2+ gradient, with
the highest Ca2+ levels in the outer SG with
lower levels in subjacent layers and SC, is evident
in both normal (A) and EHK (B) skin at baseline.
(C, D) Loss of Ca12+ gradient after tape stripping
(C) or acetone treatment (D) is accompanied by
secretion of LB (SC, stratum corneum, OSG,
outer stratum granulosum). OsO4 post®xation.
Scale bars: 1 mm.
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secretion of preformed LB from outer SG cells in EHK (Fig 10C,
D vs Fig 6; note absence of preformed LB in cytosol). These results
show that the accelerated barrier recovery of EHK skin after acute
perturbations can be explained by the release of preformed LB
contents from cells in the outer nucleated layers of the epidermis,
regulated in turn by modulations in the epidermal calcium gradient.
DISCUSSION
Keratin intermediate ®laments are the most prominent cytoskeletal
proteins of the epidermis and its appendages, accounting for up to
85% of total cellular protein (Fuchs and Coulombe, 1992; Roop,
1995). They form copolymers consisting of equimolar amounts of
at least one of two types: type I or acidic keratins (9±20) and type II
or basic keratins (1±8) (Miller et al, 1993; Steinert et al, 1993). All
keratins display a secondary structure with a central rod domain
comprising four alpha-helices and distinctive, nonhelical, head and
tail sequences. Mutations have been identi®ed in the highly
conserved ends of the rod domains of keratins 1 and 10 in several
forms of EHK (Cheng et al, 1992; Chipev et al, 1992; Rothnagel
et al, 1992), but a signi®cant proportion of affected individuals do
not have keratin 1/10 mutations (Roop, 1995; Porter et al, 1996;
Fuchs and Cleveland, 1998). EHK either occurs sporadically
(> 50%) or is inherited in an autosomal dominant fashion. Affected
individuals are born with widespread erythema and erosions. With
increased age these features diminish and are replaced by general-
ized epidermal thickening, indicative of epidermal hyperplasia
(Irvine and McLean, 1999). The resulting hyperkeratotic plaques
are prone to superinfection. The diagnosis in our patient cohort
was based on the characteristic clinical picture, diagnostic histology,
and the presence of a keratin 1 or keratin 10 mutation in two of the
four patients (Table I). Increased expression of other CE proteins
(Ishida-Yamamoto et al, 1994, 1995; Porter et al, 1996; Gerritsen
et al, 1997; Reichelt et al, 1999) could compensate for the structural
abnormality and further provoke the characteristic phenotype in
EHK. Our results con®rm previous ®ndings of increased baseline
TEWL levels in EHK patients with or without de®ned mutations
(Frost et al, 1968; Lavrijsen et al, 1993). We show further that the
initial rates of barrier repair after acute disruption actually occurred
more rapidly in EHK subjects than in controls. The basis for the
baseline permeability barrier abnormality in EHK is unknown. An
earlier hypothesis held that keratinocyte fragility could lead to
increased cytokine release, which in turn could drive the epidermal
hyperplasia, leading to a barrier abnormality (Roop, 1995).
Accordingly, we ®rst assessed whether the keratinocyte fragility
in EHK leads to a more fragile, ``leaky'' corneocyte, allowing
increased transcellular permeability. Indeed, an abnormality in
corneocyte fragility accounts for the barrier abnormality in
retinoid-treated skin, where abundant colloidal lanthanum tracer
leaks into corneocytes (Elias et al, 1981). Yet, our lanthanum
perfusion studies clearly showed that, despite the known fragility of
keratinocytes within EHK epidermis, the increased SC permeabil-
ity in EHK occurs via an intercellular rather than a transcellular
pathway. Thus, a mechanism other than an incompetent
corneocyte must be sought to explain the barrier defect. Instead,
we found both a paucity of lamellar bilayers and distorted
supramolecular architecture of those lamellar bilayers that were
present in all EHK subjects. These structural changes account for
the permeability barrier abnormality and the increased intercellular
penetration of tracer in EHK.
One mechanism whereby defective keratin 1/10 intermediate
®laments could result in abnormal extracellular lamellar bilayers
could be an abnormal CE/CLE scaffold. As keratin 1 and 10 are
crosslinked to the CE (Ming et al, 1994; Candi et al, 1998), they
could play a hitherto unrecognized role in maintenance of the SC
barrier. Accordingly, defects in the CE/CLE scaffold, even in EHK
individuals with no keratin mutations, could explain the defective
organization of extracellular lamellar bilayers in EHK. Indeed, an
analogous defect in the CE/CLE scaffold appears to be responsible
for the barrier abnormality in another keratinizing disorder with a
defect in CE formation, i.e., lamellar ichthyosis due to transglu-
taminase I mutations (Lavrijsen et al, 1993; Elias et al, 2001), and in
transgenic mice with a deletion of this enzyme (Matsuki et al,
1998). Barrier function also reportedly is abnormal in involucrin
(another CE-constituent peptide) knockout mice,2 which other-
wise display a normal phenotype (Djian et al, 2000). Finally, there is
evidence for a barrier abnormality in transgenic mice expressing a
mutant form of loricrin (Koch et al, 2000; Suga et al, 2000), the
dominant CE peptide in epidermis (Steinert, 2000). Our
ultrastructural examination did not reveal any defect of the CE/
CLE scaffold in EHK, however.
As the CE/CLE scaffold cannot be invoked to explain the barrier
defect, we next examined whether the reduction in lamellar
bilayers in EHK extracellular domains could be attributed to
decreased production (assembly, translocation) or defective secre-
tion (exocytosis) of LB. Under baseline conditions, we observed an
increased number of LB at the SG±SC interface displaying normal
organelle contents. Moreover, the secretion of LB from the
periphery of SG cells was impaired in EHK subjects. Thus, both
assembly and translocation of LB appear to be normal, but
exocytosis does not occur normally in EHK under baseline
conditions. This conclusion is further supported by two additional
observations, indicating impaired LB secretion in EHK: (i) the
presence of abundant entombed LB contents, encased within the
cytosol of corneocytes; (ii) the localization of LB-derived
hydrolytic enzymes, which normally are completely secreted,
within corneocytes and often colocalized with entombed LB
contents. As a result of the secretory abnormality, decreased LB
contents are deposited at the SG±SC interface, resulting in
discontinuous lamellar bilayers, leading in turn to increased
TEWL levels (Fig 4).
The baseline barrier abnormality in EHK is associated with
abnormal LB secretion, possibly due to an impairment of the
exocytosis step. One possible explanation is that the keratin 1/10
cytoskeletal mutation could interfere with the exocytosis of LB.
Prior work on lung epithelium and in adrenal secretory cells has
shown that the microtubular system is crucial for exocytosis (Aunis
and Bader, 1988; Zimmermann, 1989). Thus, cytoskeletal instabil-
ities, including those caused by keratin 1/10 dominant-negative
mutations in EHK, could disrupt steps that are involved in the
exocytosis of LB. A precise link between the keratin 1/10
mutations and the barrier abnormality could not be established
here, however, not only because only half of our patients had these
mutations, but also because of limitations of experiments in humans
in vivo. Animal models with de®ned defects in keratins 1/10 should
allow a further dissection of the molecular pathogenesis of the LB
secretory abnormality, however. Several putative mouse models of
the disease have been described (Fuchs et al, 1992; Bickenbach et al,
1996; Porter et al, 1996; Reichelt et al, 1997), but available data on
the permeability barrier abnormalities in these animal models do
not always re¯ect the structural and functional abnormalities of
EHK, presumably because the murine genotypes do not always
re¯ect EHK (Reichelt et al, 1999; Elias et al, 2000a; Jensen et al,
2000).
After acute barrier disruption the peripheral arrays of LB in
granular cells were rapidly released (Fig 9), accounting for the
accelerated recovery of permeability barrier function in EHK skin.
Moreover, we found an increase in intact lamellar bilayers and
exclusion of lanthanum tracer from the extracellular domains after
acute barrier disruption. The basis for the release of LB after acute
disruption probably does not simply re¯ect cytolysis of fragile cells
with release of trapped LB. Among likely explanations could be the
presence of an intact calcium gradient in EHK under baseline
conditions, which, together with the mutant protein, restricts
secretion. The effect of the mutant protein can be temporarily
2Jensen JM, Djian P, Proksch E: Disturbed permeability barrier function
in transgenic involucrin de®cient mice. J Invest Dermatol 112: 542, 1999
(abstr.)
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overcome by the complete calcium depletion that occurs after
barrier disruption (Fig 10). Alternatively, the expression of the
mutant protein could be downregulated after acute disruption,
thereby allowing unrestricted LB secretion until the calcium
gradient is re-established. To date, however, there is evidence that
keratins 1/10 are actually upregulated after barrier disruption
(Ekanayake-Mudiyanselage et al, 1998). Lastly, the pathway for LB
secretion could differ under baseline versus stimulated conditions. In
any case, the localization of arrays of unsecreted LB at the SG±SC
interface under baseline conditions seems to re¯ect a ``geared-up''
activation state, which after an external assault is quickly trans-
formed into a normal or supernormal repair response. A similar
acceleration of the early phase of barrier repair kinetics has been
reported for atopic dermatitis (Gfesser et al, 1997), but no
information is available as yet for the morphologic basis of
accelerated repair in atopic dermatitis.
In summary, the permeability barrier abnormality in EHK can be
attributed to increased intercellular water movement, despite the
known fragility of keratinocytes. The barrier abnormality correlates
with a reduction in extracellular lamellar membranes, which can be
attributed further to impaired LB secretion. The baseline abnor-
mality can be overcome by application of external stimuli for
barrier repair.
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